Taysha Gene Therapies Inc (TSHA) is a biotechnology company listed on US.
Latest reported TSHA revenue for 2026-06-30 was $0. Net income was -$89.0M. TSHA currently screens at market cap $640.7M.
Use this TSHA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TSHA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TSHA SEC filings page. Lician reads the product cache first so this HTML stays unique to Taysha Gene Therapies Inc even when a live quote feed is slow.
Latest cached year on this hub. Full TSHA income, balance, and cash tables.